Patents Assigned to Critichem Medical Products Limited
  • Early diagnosis of sepsis utilizing antigen-antibody interactions amplified by whole blood chemiluminescence
    Patent number: 5804370
    Abstract: The invention relates to a method for determining the extent of sepsis and/or an infection in a human or animal patient by detecting the amount of an antigen indicative of such infection. The amount of the antigen is detected in a patient blood derived test sample containing blood cell fractions.
    Type: Grant
    Filed: November 2, 1995
    Date of Patent: September 8, 1998
    Assignee: Critichem Medical Products Limited
    Inventors: Alex D. Romaschin, Paul M. Walker